These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Biochemistry of risk factors for cardiovascular diseases in laboratory medicine]. Okabe H Rinsho Byori; 1996 Nov; 44(11):1050-7. PubMed ID: 8953935 [TBL] [Abstract][Full Text] [Related]
6. Lipid and lipoprotein metabolism in chronic kidney disease. Kaysen GA J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776 [TBL] [Abstract][Full Text] [Related]
7. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Langsted A; Freiberg JJ; Nordestgaard BG Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664 [TBL] [Abstract][Full Text] [Related]
8. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins. Heller M; Stalder D; Schlappritzi E; Hayn G; Matter U; Haeberli A Proteomics; 2005 Jul; 5(10):2619-30. PubMed ID: 15892164 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P; Kannan NK J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [TBL] [Abstract][Full Text] [Related]
10. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Carter CJ Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241 [TBL] [Abstract][Full Text] [Related]
12. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: effects of apolipoproteins. Dallinga-Thie GM; Dullaart RP; van Tol A Curr Opin Lipidol; 2007 Jun; 18(3):251-7. PubMed ID: 17495597 [TBL] [Abstract][Full Text] [Related]